-
BIO Integration, Volume 4, Issue Number 3, Publishes
Guangzhou, November 7, 2023: BIO Integration (BIOI) publishes volume 4, issue 3. BIOI is a peer-reviewed, open access, international journal, which is dedicated to spreading multidisciplinary views driving the advancement…
-
Anti-diabetic Research on Two Important Spices: Trachyspermum ammi and Pimpinella anisum
Announcing a new article publication for BIO Integration journal. Diabetes mellitus (DM) arises from a cascade of factors, primarily stemming from defective insulin secretion by the pancreas and emergence of…
-
Single-Cell RNA-Sequencing Integration Analysis Revealed Immune Cell Heterogeneity in Five Human Autoimmune Diseases
Announcing a new article publication for BIO Integration journal. Autoimmune diseases are a group of diseases caused by abnormal immune responses to functional body parts. Single-cell RNA-sequencing (scRNA-seq) technology provides…
-
HNP-1 Reverses Hypertensive Left Ventricular Hypertrophy by Inhibiting the NF-кB Signaling Pathway
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Human neutrophil peptide-1 (HNP-1) is a commonly investigated therapeutic agent. However, its role in hypertensive left ventricular hypertrophy (HLVH)…
-
Embedding R inside the PhysPK Bio-simulation Software for Pharmacokinetics Population Analysis
Announcing a new article publication for BIO Integration journal. PhysPK stands as a flexible and robust bio-simulation and modeling software designed for analysis of population pharmacokinetics (PK) and pharmacodynamics (PD)…
-
BIO Integration, Volume 4, Issue Number 2, Publishes
Guangzhou, September 7, 2023: BIO Integration (BIOI) publishes volume 4, issue 2. BIOI is a peer-reviewed, open access, international journal, which is dedicated to spreading multidisciplinary views driving the advancement…
-
First experiments with carbon black pigment dispersion acting as a Janus ultrasound contrast agent
Announcing a new article publication for BIO Integration journal. Theranostic ultrasound contrast agents comprise a therapeutic component whose controlled release is triggered by an ultrasound pulse. However, once the therapeutic…
-
Peptide Assemblies as Promising Tumor Vaccines: Current Platforms and Progress
Announcing a new article publication for BIO Integration journal. Self-assembled peptide-based vaccines, consisting of epitope-bearing peptides, can form diverse nanostructural morphologies, which could be endocytosed and presented by DCs to…